These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 28842349

  • 21. Development and Evaluation of Solidified Supersaturated SNEDDS Loaded with Triple Combination Therapy for Metabolic Syndrome.
    Sherif AY, Alshora DH, Ibrahim MA, Jreebi A.
    AAPS PharmSciTech; 2024 Sep 06; 25(7):209. PubMed ID: 39237698
    [Abstract] [Full Text] [Related]

  • 22. Formulation and Pharmacokinetic Evaluation of Phosal Based Zaltoprofen Solid Self-Nanoemulsifying Drug Delivery System.
    Kalamkar R, Wadher S.
    Pharm Nanotechnol; 2019 Sep 06; 7(4):328-338. PubMed ID: 31376828
    [Abstract] [Full Text] [Related]

  • 23. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
    Miao Y, Chen G, Ren L, Pingkai O.
    Drug Deliv; 2016 Sep 06; 23(7):2163-2172. PubMed ID: 25148542
    [Abstract] [Full Text] [Related]

  • 24. Formulation of solid self-nanoemulsifying drug delivery systems using N-methyl pyrrolidone as cosolvent.
    Agrawal AG, Kumar A, Gide PS.
    Drug Dev Ind Pharm; 2015 Apr 06; 41(4):594-604. PubMed ID: 24517575
    [Abstract] [Full Text] [Related]

  • 25. Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability.
    Gamal W, Fahmy RH, Mohamed MI.
    Drug Dev Ind Pharm; 2017 Sep 06; 43(9):1530-1538. PubMed ID: 28447878
    [Abstract] [Full Text] [Related]

  • 26. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
    Singh B, Khurana L, Bandyopadhyay S, Kapil R, Katare OO.
    Drug Deliv; 2011 Nov 06; 18(8):599-612. PubMed ID: 22008038
    [Abstract] [Full Text] [Related]

  • 27. Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems--enhancement of oral bioavailability.
    Hashem FM, Al-Sawahli MM, Nasr M, Ahmed OA.
    Drug Des Devel Ther; 2015 Nov 06; 9():3141-52. PubMed ID: 26150693
    [Abstract] [Full Text] [Related]

  • 28. A comprehensive study of the basic formulation of supersaturated self-nanoemulsifying drug delivery systems (SNEDDS) of albendazolum.
    Alothaid H, Aldughaim MS, Yusuf AO, Yezdani U, Alhazmi A, Habibullah MM, Khan MG.
    Drug Deliv; 2021 Dec 06; 28(1):2119-2126. PubMed ID: 34612775
    [Abstract] [Full Text] [Related]

  • 29. Formulation development of self-nanoemulsifying drug delivery system of celecoxib for the management of oral cavity inflammation.
    Salem HF, Kharshoum RM, Sayed OM, Abdel Hakim LF.
    J Liposome Res; 2019 Jun 06; 29(2):195-205. PubMed ID: 30221598
    [Abstract] [Full Text] [Related]

  • 30. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
    Rashid R, Kim DW, Yousaf AM, Mustapha O, Fakhar Ud Din, Park JH, Yong CS, Oh YK, Youn YS, Kim JO, Choi HG.
    Int J Nanomedicine; 2015 Jun 06; 10():6147-59. PubMed ID: 26491288
    [Abstract] [Full Text] [Related]

  • 31. Quality by Design Approach for Developing Lipid-Based Nanoformulations of Gliclazide to Improve Oral Bioavailability and Anti-Diabetic Activity.
    Patel P, Pailla SR, Rangaraj N, Cheruvu HS, Dodoala S, Sampathi S.
    AAPS PharmSciTech; 2019 Jan 07; 20(2):45. PubMed ID: 30617566
    [Abstract] [Full Text] [Related]

  • 32. Development and Optimization of Solid Self Nanoemulsifying Drug Delivery (S-SNEDDS) Using D-Optimal Design for Improvement of Oral Bioavailability of Amiodarone Hydrochloride.
    Patel A, Shelat P, Lalwani A.
    Curr Drug Deliv; 2015 Jan 07; 12(6):745-60. PubMed ID: 25731867
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.